4.8 Article

Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma

Journal

SCIENCE
Volume 333, Issue 6048, Pages 1453-1455

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1210557

Keywords

-

Funding

  1. Virginia
  2. D. K. Ludwig Fund for Cancer Research
  3. Pediatric Brain Tumor Foundation
  4. Duke Comprehensive Cancer Center Core
  5. Burroughs Wellcome Fund
  6. James S. McDonnell Foundation
  7. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12433-6, 01/12898-4]
  8. National Cancer Institute Division of Cancer Prevention [N01-CN-43302]
  9. National Institutes of Health [CA43460, CA57345, CA11898, CA121113, CA62924, RC2DE020957, NS20023]
  10. NIH/NCI Institutional National Research Service [T32 CA009574]

Ask authors/readers for more resources

Oligodendrogliomas are the second most common malignant brain tumor in adults and exhibit characteristic losses of chromosomes 1p and 19q. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven tumors. Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins. These results suggest a critical role for these genes in the biology and pathology of oligodendrocytes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available